The market performance of Mereo Biopharma Group Plc ADR’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $4.36 on 02/05/24, while the lowest value for the same duration was $0.86 on 05/31/23.
52-week price history of MREO Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Mereo Biopharma Group Plc ADR’s current trading price is -37.16% away from its 52-week high, while its distance from the 52-week low is 218.60%. The stock’s price range during this period has spanned from $0.86 to $4.36. In the Healthcare sector, the Mereo Biopharma Group Plc ADR’s shares surpassed a trading volume of approximately 1.65 million for the day, which was noticeably lower compared to the average daily volume of 9.1.75 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Mereo Biopharma Group Plc ADR (MREO) has experienced a quarterly decline of -1.08% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 383.76M and boasts a workforce of 33 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.98, with a change in price of +0.54. Similarly, Mereo Biopharma Group Plc ADR recorded 1,436,789 in trading volume during the last 100 days, posting a change of +24.55%.
Examining MREO’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for MREO stands at 0.16. Similarly, the long-term debt-to-equity ratio is also 0.08.
MREO Stock Stochastic Average
Today’s raw stochastic average for Mereo Biopharma Group Plc ADR over the last 50 days is 1.22%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 2.63%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 16.29% and 28.93%, respectively.
MREO Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The metric has seen a significant gain of 18.61% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 114.06%. Over the past 30 days, the price of MREO has leaped by -21.71%. And in the last five days, it has fallen by -15.95%.
